Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Leukemia × Doxorubicin × Clear all

Sponsor

Conditions

Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Lymphoma, T-Cell 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1 Lymphoma 1 Hematologic Diseases 1 Endometrial Neoplasms 1 Burkitt Lymphoma 1 Ann Arbor Stage IIB Hodgkin Lymphoma 1

Interventions

blinatumomab 3 Cytarabine 3 venetoclax 2 revumenib 2 Daunorubicin 2 quizartinib 1 obinutuzumab 1 nilotinib 1 ivosidenib 1 etoposide phosphate 1 bosutinib 1 acalabrutinib 1 Mitoxantrone 1 Midazolam 1 Itraconazole 1 Imatinib Mesylate 1 Idarubicin 1 Gemtuzumab 1 Etoposide 1 Drug Therapy 1 Cobicistat 1 Azacitidine 1 Asparaginase 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡